
Dermazit 0.025% Lotion
Marketer
Zither Pharmaceutical Pvt Ltd
Salt Composition
Beclometasone (0.025% w/v)
Overview Dermazit 0.025% Lotion
Steroidal lotion Dermazit 0.025% treats inflammatory skin conditions like dermatitis and psoriasis. It reduces swelling, itching, and redness by inhibiting inflammation-inducing substances. Apply Dermazit 0.025% topically only, as prescribed by your physician. Cleanse and dry the affected skin before applying a thin, even layer. Strictly adhere to the prescribed dosage and frequency. Avoid occlusive dressings (e.g., bandages) to minimize potential side effects. Common, usually transient side effects include application-site burning, irritation, itching, and redness. Persistent or worsening symptoms warrant medical attention. Pregnant or breastfeeding individuals should consult their doctor before use.
Primary Ingredients of Dermazit 0.025% Lotion
No information provided. Please provide the text you wish me to rephrase.
Uses of Dermazit 0.025% Lotion
Inflammatory dermatoses accompanied by pruritus
Major Benefits of Dermazit 0.025% Lotion:
Apply this medication topically only. Follow your doctor's instructions precisely regarding dosage and treatment length. Ensure thorough shaking before evenly distributing to the affected zone.
Common Side effects of Dermazit 0.025% Lotion:
- Hoarseness of voice
- Thrush
- Pharyngitis
- Abnormal taste
- Nasopharyngeal irritation
- Application site irritation
- Application site burning
How to use Dermazit 0.025% Lotion:
Apply this medication topically only. Follow your physician's instructions precisely regarding dosage and treatment length. Ensure thorough shaking before even application to the affected zone.
How Dermazit 0.025% Lotion works:
Steroidal lotion Dermazit (0.025%) reduces inflammation by inhibiting the synthesis of prostaglandins, inflammatory mediators responsible for skin redness, swelling, and pruritus.
SAFETY ADVICE
AlcoholNone
No known drug interactions.
PregnancyCONSULT YOUR DOCTOR
The use of Dermazit 0.025% Lotion during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. Prescribing this medication will involve a risk-benefit assessment by your physician. Seek medical advice before using this lotion.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the application of Dermazit 0.025% Lotion are likely incompatible. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingNone
No known drug interactions.
KidneyNone
No drug interactions identified.
LiverNone
No known drug interactions.
What if you forget to take Dermazit 0.025% Lotion :
Should you forget a Dermazit 0.025% Lotion application, use it promptly. Nevertheless, if your next scheduled application is imminent, omit the missed one and resume your usual regimen. Never apply a double dose.
Facts to Know About Dermazit 0.025% Lotion
| Label | Value |
|---|---|
| Chemical Category | Glucocorticoids, mineralocorticoids, progestins, and their derivatives |
| Developing Habits | No. |
| Treatment Category | DERMA |
